Clinical trial Recruiting at 31 sites Interventional Ages 18 and up

Comparing two methods for treating wide-neck abdominal aortic aneurysms

Official title: Randomized Controlled Clinical Trial on the Application of Heli-FX EndoAnchors in Conjunction With the Endurant II/IIs Endograft in Infrarenal Aortic Aneurysms With a Wide Infrarenal Neck (HERCULES Trial)

Run by Rijnstate Hospital · NCT05484115 · Data updated 2026-11-12

This study is testing whether a new way to repair wide-neck abdominal aortic aneurysms works better than the standard method for patients with this condition.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorRijnstate Hospital
Academic / other
Locations36 sites (Washington, Arkansas and 35 other locations)
StatusRecruiting
StartedMay 26, 2023
Main results expectedApril 2029
Study endsApril 2033
Registry record updatedMay 11, 2026
Trial IDNCT05484115 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 years or older with infrarenal aortic aneurysms and proximal neck diameters between 28 mm and 32 mm.

Probably not a fit

Patients with anatomical features outside the guidelines for the Endurant II/IIs stent graft system and Heli-FX EndoAnchor system will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The HERCULES trial is a randomized controlled clinical trial that aims to compare the clinical outcomes of endosuture aneurysm repair (ESAR) using the Heli-FX EndoAnchor system against standard endovascular aneurysm repair (EVAR) with the Endurant II/IIs stent graft system. This multicenter trial will recruit up to 300 subjects across 40 sites in Europe and the US, focusing on patients with infrarenal abdominal aortic aneurysms that have wide proximal neck diameters. Participants will be followed for up to five years to assess the effectiveness and safety of both treatment methods. The study is designed to fill the gap in clinical evidence regarding these two approaches in this specific patient population.

Why it matters

Potential benefit: If successful, this study could provide more effective treatment options for patients with wide-neck abdominal aortic aneurysms, potentially improving their outcomes.

How similar studies have gone: While both treatment methods are commercially approved, this study is novel as it specifically compares their effectiveness in patients with wide proximal neck diameters, an area where clinical evidence is currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Provided written informed consent
* Clinical necessity for treatment of the AAA, according to the current guidelines in the geographies participating
* Elective repair
* Eligible anatomy for treatment with the Endurant II/IIs stent graft system and Heli-FX EndoAnchor system according to the IFU of both devices
* Infrarenal neck diameter ≥ 28 mm and ≤32 mm
* Proximal neck length ≥10mm

Exclusion Criteria:

* Anatomy outside the IFU of the ndurant II/IIs stent graft system and Heli-FX EndoAnchor system
* Planned use of AUI main body device
* Patient is participating in another clinical study, potentially conflicting with the outcomes of the current study.
* Patient with eGFR \< 30 ml/min/1.73m2 before the intervention
* Patient's life expectancy \<2 years as judged by the investigator
* Patient has a psychiatric or other condition that may interfere with the study
* Patient has a known allergy to any device component
* Patients with a systemic infection who may be at increased risk of endovascular graft infection.
* Patient has a coagulopathy or uncontrolled bleeding disorder
* Patient has a ruptured, leaking, or mycotic aneurysm
* Patient is not eligible for standard EVAR
* Patient had a Cerebro Vascular Accident (CVA) or a myocardial infarction (MI) within the prior three months
* Patient is pregnant (Female patients of childbearing potential only)
* Patient has active COVID-19 infection or has been diagnosed with long COVID-19 requiring hospitalization within the 6 months prior to procedure.
* Patient has previously been treated with stent grafts in the aorto-iliac arteries

Where it's running

  • Washington Regional Medical Center
    Washington, Arkansas, United States
    Recruiting
  • Mt Sinai Med Ctr
    Miami Beach, Florida, United States
    Recruiting
  • Loyola
    Maywood, Illinois, United States
    Recruiting
  • Beaumont University Hospital
    Royal Oak, Michigan, United States
    Recruiting
  • Alina Health
    Minneapolis, Minnesota, United States
    Recruiting
  • University of Missouri
    Columbia, Missouri, United States
    Recruiting
Show 30 more locations
  • Barnes-Jewish Hospital
    St Louis, Missouri, United States
    Recruiting
  • Robert Wood Johnson University Medical Center
    New Brunswick, New Jersey, United States
    Recruiting
  • Sisters of Charity hospital
    Buffalo, New York, United States
    Recruiting
  • Stony Brook University Medical Center
    Stony Brook, New York, United States
    Recruiting
  • NC Heart& Vascular
    Raleigh, North Carolina, United States
    Recruiting
  • Promedica Toledo Hospital
    Toledo, Ohio, United States
    Recruiting
  • Penn State Health Milton S. Hershey Medical Center
    Hershey, Pennsylvania, United States
    Recruiting
  • Ballad Health/Holston Valley
    Kingsport, Tennessee, United States
    Recruiting
  • Virginia Commonwealth University (VCU)
    Richmond, Virginia, United States
    Recruiting
  • HCL Lyon
    Lyon, France
    Recruiting
  • Saint Joseph Marseille
    Marseille, France
    Recruiting
  • Les Franciscaines
    Nîmes, France
    Recruiting
  • Asklepios Klinik Langen
    Langen, Hesse, Germany
    Recruiting
  • University Hospital Leipzig
    Leipzig, Germany
    Recruiting
  • IRCCS Ospedale Policlinico San Martino
    Genova, Metropolitan City of Genoa, Italy
    Recruiting
  • Osp. S.Orsola Malpighi - Bologna
    Bologna, Italy
    Recruiting
  • Rijnstate hospital
    Arnhem, Netherlands
    Recruiting
  • Catharina Ziekenhuis
    Eindhoven, Netherlands
    Recruiting
  • Hospital Clinic de Barcelona
    Barcelona, Spain
    Recruiting
  • Hospital Clinico Universitario Lozano Blesa
    Zaragoza, Spain
    Recruiting
  • EHC-Hôpital de Morges
    Morges, Switzerland
    Recruiting
  • Queen Elizabeth University Hospital, Glasgow
    Glasgow, United Kingdom
    Recruiting
  • Leeds General Infirmary
    Leeds, United Kingdom
    Recruiting
  • St. George's Hospital
    London, United Kingdom
    Recruiting
  • St. Mary's Hospital
    London, United Kingdom
    Recruiting
  • Henry Ford Hospital
    Detroit, Michigan, United States
    Not yet recruiting
  • Universitatsklinikum Frankfurt
    Frankfurt, Germany
    Not yet recruiting
  • Noordwest ziekenhuis
    Alkmaar, North Holland, Netherlands
    Not yet recruiting
  • Spaarne Gasthuis
    Haarlem, North Holland, Netherlands
    Not yet recruiting
  • Hospital Universitario Miguel Servet
    Zaragoza, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.